Evidence map›Paper›PMID 34072459›Full record

ArticleMetabolites2021

Metabolomics in the Identification of Biomarkers of Asthma.

Alma Villaseñor, Ibon Eguiluz-Gracia, André Moreira, Craig E Wheelock, María M Escribese

Abstract readEditorial
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Clinical implications of asthma endotypes and phenotypes.Allergy and asthma proceedings · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alma VillaseñorDepartment of Basic Medical Sciences, Facultad de Medicina, Institute of Applied Molecular Medicine (IMMA), Universidad San Pablo CEU, CEU Universities, 28660 Madrid, Spain.ORCID 0000-0002-6652-2739
Ibon Eguiluz-GraciaAllergy Group, Instituto de Investigacion Biomedica de Malaga (IBIMA) and ARADyAL, 29009 Malaga, Spain.ORCID 0000-0002-3774-931X
André MoreiraEPI Unit, Instituto de Saúde Pública, Universidade do Porto, 4050-600 Porto, Portugal.ORCID 0000-0002-7294-9296
Craig E WheelockDivision of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Biomedicum Quartier 9A, SE-171-77 Stockholm, Sweden.ORCID 0000-0002-8113-0653
María M EscribeseDepartment of Basic Medical Sciences, Facultad de Medicina, Institute of Applied Molecular Medicine (IMMA), Universidad San Pablo CEU, CEU Universities, 28660 Madrid, Spain.ORCID 0000-0001-5057-5150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a major non-communicable disease characterized by recurrent attacks of breathlessness and wheezing [...].

Identifiers

PMID34072459
PMCPMC8227545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.